The proposed study is designed to examine gene expression, ligand recognition and structure of two major post-synaptic proteins in the cholinergic nervous acetylcholinesterase and the nicotinic acetylcholine receptors. These proteins work in concert in many cholinergic synapses to achieve the appropriate fidelity of neurotransmission in the brain and periphery and are the targets of several pharmacologic agents. Our approach relies on expression of these proteins from their cloned genes, site-specific mutagenesis and analysis of ligand binding and structure through studying specificity of peptide toxins, fluorescence spectroscopy and X-ray crystallography. In particular, we plan to study the interaction of the three fingered peptide, fasciculin with acetylcholinesterase to correlate the residues contributing to the binding energy with the structure of the wild-type and mutant complexes determined by X-ray crystallography. We also plan to examine the portals of entry of small substrates into fasciculin complexes acetylcholinesterase. Since the enzyme functions at diffusion-controlled rates, despite having its active center deep in a gorge, we plan to use decay of fluorescence anisotropy to examine whether flap-like motions of a domain or more rapid breathing motions govern ligand entry into the gorge. Other structural investigations with cholinesterase involve its comparison with the homologous alpha/beta hydrolase-fold protein, neuroligin, in order to delineate regions of non-catalytic functions in the two molecules. Studies with the nicotinic receptors rely on toxins selective for particular binding interfaces (alpha-conotoxin M-1, delta subunit; waglerin, epsilon subunit; N. mossambica mossambica alpha- neurotoxin, gamma and delta but not epsilon subunits). From site- specific mutagenesis on the alpha-toxin and receptor, we will employ thermodynamic mutant cycle analysis to ascertain proximities of amino acid residues in the complex. This information will be used to model toxin binding to receptors. We will also attempt to develop a x-ray crystal structure based template of the extracellular domain of th receptor to enhance structural information for these studies. Finally, studies on acetylcholinesterase gene expression will be continued with particular emphasis on tissue specific expression and splicing in differentiating muscle. The first intron, 5' of the translation start site, appears critical for the enhanced expression associated with muscle specific expression and splicing in differentiating muscle. The first intron, 5' of the translation start site appears critical for the for the enhanced expression associated with muscle specific expression and we plan to delineate how this region serves as an enhancer or repressor of trans transcriptional activity and whether it influences the transport of mRNA from the nucleus.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37GM018360-30
Application #
6385013
Study Section
Pharmacology A Study Section (PHRA)
Program Officer
Cole, Alison E
Project Start
1975-01-01
Project End
2004-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
30
Fiscal Year
2001
Total Cost
$581,687
Indirect Cost
Name
University of California San Diego
Department
Pharmacology
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Molgó, Jordi; Marchot, Pascale; Aráoz, Rómulo et al. (2017) Cyclic imine toxins from dinoflagellates: a growing family of potent antagonists of the nicotinic acetylcholine receptors. J Neurochem 142 Suppl 2:41-51
Mangas, I; Taylor, P; Vilanova, E et al. (2016) Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches. Arch Toxicol 90:603-16
Bourne, Yves; Sulzenbacher, Gerlind; Radi?, Zoran et al. (2015) Marine Macrocyclic Imines, Pinnatoxins A and G: Structural Determinants and Functional Properties to Distinguish Neuronal ?7 from Muscle ?1(2)??? nAChRs. Structure 23:1106-15
Arunrungvichian, Kuntarat; Fokin, Valery V; Vajragupta, Opa et al. (2015) Selectivity optimization of substituted 1,2,3-triazoles as ?7 nicotinic acetylcholine receptor agonists. ACS Chem Neurosci 6:1317-30
Kaczanowska, Katarzyna; Harel, Michal; Radi?, Zoran et al. (2014) Structural basis for cooperative interactions of substituted 2-aminopyrimidines with the acetylcholine binding protein. Proc Natl Acad Sci U S A 111:10749-54
Benyamin, Beben; Middelberg, Rita P; Lind, Penelope A et al. (2011) GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factors. Hum Mol Genet 20:4504-14
Bernard, Véronique; Girard, Emmanuelle; Hrabovska, Anna et al. (2011) Distinct localization of collagen Q and PRiMA forms of acetylcholinesterase at the neuromuscular junction. Mol Cell Neurosci 46:272-81
Bourne, Yves; Radic, Zoran; Aráoz, Rómulo et al. (2010) Structural determinants in phycotoxins and AChBP conferring high affinity binding and nicotinic AChR antagonism. Proc Natl Acad Sci U S A 107:6076-81
Comoletti, Davide; Miller, Meghan T; Jeffries, Cy M et al. (2010) The macromolecular architecture of extracellular domain of alphaNRXN1: domain organization, flexibility, and insights into trans-synaptic disposition. Structure 18:1044-53
Leone, Philippe; Comoletti, Davide; Ferracci, Geraldine et al. (2010) Structural insights into the exquisite selectivity of neurexin/neuroligin synaptic interactions. EMBO J 29:2461-71

Showing the most recent 10 out of 69 publications